BREAKING: $BSX to acquire Penumbra ($PEN) — Merger Agreement filed; Penumbra will become a wholly owned…
Filed with the SEC on · Summarized by InvestorsBot
BREAKING: $BSX to acquire Penumbra ($PEN) — Merger Agreement filed; Penumbra will become a wholly owned subsidiary. Shareholders can elect $374 cash OR 3.8721 $BSX shares per Penumbra share (subject to proration). 🚨🤝 #M&A #MedTech #BREAKING #Stocks
ALERT: What this means — material, deal-moving acquisition: $BSX will issue stock, assume/convert Penumbra awards, and materially change capital structure. Elections are prorated: 73.26% cash / 26.74% stock. Closing needs HSR, S‑4 & vote. 🗳️📈 #Investing #Mergers
Confirmed: Option/RSU treatment — in‑the‑money Penumbra options convert to $274 cash + 1.0353 $BSX shares (VWAP-based); many RSUs vest/convert or are assumed. Termination fees: $525M (if PEN takes superior bid) & $900M (if regs block after approval). 💰⚖️ #FinTwit #Deal
ALERT: Next steps — $BSX will file a Form S‑4, Penumbra will convene a stockholder meeting. Closing contingent on regulatory clearances, NYSE listing approval & no material adverse effects — antitrust/HSR risk could delay or derail. 📄⚖️ $BSX $PEN #DueDiligence #Antitrust